Skip to search.
 TSX Down 0.19% TSX Ventures Up 0.14%

Acorda Therapeutics, Inc. (ACOR)

-NasdaqGS
20.88 Up 0.24(1.16%) 4:00PM EDT
|After Hours : 20.88 0.00 (0.00%) 4:59PM EDT
Prev Close:20.64
Open:20.75
Bid:20.77 x 100
Ask:21.82 x 1600
1y Target Est:39.64
Beta:0.960882
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:20.51 - 21.15
52wk Range:20.51 - 43.63
Volume:924,257
Avg Vol (3m):576,591
Market Cap:963.40M
P/E (ttm):N/A
EPS (ttm):-0.14
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ACORUp 1.16%963.40M
BIIBUp 2.37%68.59B

Key Statistics

Forward P/E (1 yr):30.71
P/S (ttm):1.82
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :0.47
Quarterly EPS Est (Sep-16) :0.11
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):1.51

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Acorda Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and commercializes novel therapies for neurological disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback